PF-08046044/SGN-35C

· Seagen (a wholly owned subsidiary of Pfizer)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-08046044/SGN-35C, covering 2026-04-23 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Safety Study of PF-08046044/SGN-35C in Adults With Advanced Cancers [Phase 1]